Tacrolimus/cerivastatin interaction study in liver transplant recipients
about
Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective studyDiabetes and other endocrine-metabolic abnormalities in the long-term follow-up of pancreas transplantation.Tacrolimus and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: An interaction study in CYP3A5 non-expressors, renal transplant recipients.Tacrolimus and cerivastatin pharmacokinetics and adverse effects after single and multiple dosing with cerivastatin in renal transplant recipients
P2860
Tacrolimus/cerivastatin interaction study in liver transplant recipients
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@ast
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@en
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@nl
type
label
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@ast
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@en
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@nl
prefLabel
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@ast
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@en
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@nl
P2093
P2860
P3181
P1476
Tacrolimus/cerivastatin interaction study in liver transplant recipients
@en
P2093
P2860
P3181
P356
10.1046/J.0306-5251.2001.01424.X
P407
P577
2001-08-01T00:00:00Z